Tag: Johnson and Johnson

Posted on

Net Result of the Johnson and Johnson Vaccine Pause is the most Vulnerable remain Vulnerable

external content.duckduckgo

the staff of the Ridgewood blog

Ridgewood NJ, on April 6th the Village of Ridgewood announced it has has just received the single dose  Johnson and Johnson vaccine. The Johnson and Johnson  vaccine was “paused” by the CDC and FDA on April 13th.

Dr. Nirav Shah, president of the Association of State Territorial Health Officers and the director of the Maine CDC gave some very profound testimony on the Johnson and Johnson pause:

Continue reading Net Result of the Johnson and Johnson Vaccine Pause is the most Vulnerable remain Vulnerable

Posted on

CDC Now Says Vaccinated People can Safely Gather Indoors without Masks

external content.duckduckgo 17

the staff of the Ridgewood blog

Ridgewood NJ, new guidelines from the Centers for Disease Control and Prevention (CDC) suggest it is safe for fully vaccinated people to gather indoors with each other without masks. “If you and a friend, or you and a family member are both vaccinated, you can have dinner together” without wearing masks or without distancing, CDC Director Rochelle Walensky told reporters on Monday.

Continue reading CDC Now Says Vaccinated People can Safely Gather Indoors without Masks

Posted on

Dr. Fauci says all three Covid vaccines highly effective, urges people to take shot most available

0

the staff of the Ridgewood blog

Washington DC, the White House Chief Medical Advisor Dr. Anthony Fauci said on Sunday he would take the newly approved Johnson & Johnson Covid-19 vaccine and urged Americans to take whichever shot is available when they are eligible.

Continue reading Dr. Fauci says all three Covid vaccines highly effective, urges people to take shot most available

Posted on

FDA Issues Emergency Use Authorization for Johnson & Johnson Sigle Dose COVID Vaccine

c9215d4f 47bf 4fbe ad5a 570047c8daf0

the staff of the Ridgewood blog

Washington DC, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the third vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older.

Continue reading FDA Issues Emergency Use Authorization for Johnson & Johnson Sigle Dose COVID Vaccine

Posted on

Johnson & Johnson (J&J) published preliminary findings for COVID19 Vaccine

64310182 10156106202320951 9163112232647655424 n
the staff of the Ridgewood blog
New Brunswick NJ,  according to Johns Hopkins Center for Health Security , Johnson & Johnson (J&J) published (preprint) preliminary findings from the Phase 1/2a clinical trials for its candidate SARS-CoV-2 vaccine (Ad26.COV.S). The studies included nearly 800 participants, who were split into 3 cohorts for the randomized, double-blinded, placebo-controlled study. The first 2 cohorts were made up of 402 healthy adults aged 18-55 years, and the third cohort included 394 healthy adults over the age of 65. The vaccine was given as a single dose or 2 doses administered 56 days apart. The vaccine was generally well tolerated, and the researchers reported 2 serious adverse events. One of the serious adverse events was determined to be unrelated to the vaccine, and the other was a fever that resolved within 12 hours.

Continue reading Johnson & Johnson (J&J) published preliminary findings for COVID19 Vaccine